From: Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice
Group (n = 5)
No. of brain cysts*
Reduction (%)#
CAV-2-ROP18 (I)
8000 ± 1414a
57.3
CAV-2 (II)
17480 ± 1584b
6.6
PBS (III)
18080 ± 642b
3.4
Blank Control (IV)
18720 ± 955b
-